Assistance Publique Des Hopitaux de Marseille
Marseille, PACA, 13005, France
NCT Number: NCT03592589
Anesthesia causes respiratory changes and complications, which are the main causes of complications and anesthesia-related deaths.
Among the complications, the rapid appearance of lung atelectasis is well known, deteriorating the hematosis during anesthesia, and inducing secondary pulmonary complications.
Prevention or limitation of the atelectasis would be a way to improve the safety of patients who have a limited respiratory function.
The application of a positive expiratory pressure (PEP) is an effective prevention method for atelectasis, that have been only demonstrate in patients under mechanical ventilation.
The high flow nasal cannula is a non-invasive technique easy to perform and allowing a PEP. High flow nasal cannula is safe to use, and the interface is free from local skin complications.
Chest X-ray (bad sensibility) or CT are usually used for the diagnosis of atelectasis, but these two exams involve irradiation for patient. MRI and pulmonary ultrasonography has now been validated in adults. MRI are relatively long, and allow to investigate the atelectasis with only a short additional acquisition time.
Thus, it would be the first study on the effect of the PEP on the impact and the volume of the atelectasis during general anesthesia in spontaneous ventilation in children. By the way this is the first study on lung's anatomical effects of high flow nasal cannula.
It is a monocentric, intervention, randomized, superiority study whose main purpose is to show the reduction of the atelectasis through the use of high flow nasal cannula versus a high concentration mask for pediatric anesthesia during MRI.
The studied population is all the children between 6 months and 5 years with a pediatric indication of general anesthesia for MRI.
The primary goal is to show a reduction of volume (cm3) of the atelectasis via the application of a PEP by high flow nasal cannula.
The main assessment criteria is the ratio of atelectasis volume/total lung volume.
The prevalence of the atelectasis will be evaluated by MRI lung and measured using 3D reconstruction software. The duration of the examination and the anesthesia is slighty lengthened, 3 to 5 minutes for a 40 minutes' exam.
The secondary objective is to show a match between the atelectasis on MRI and ultrasound.
Looking for future studies?
Notify Me6 month–5 year
All sexes
Interventional
Not applicable
Marseille, PACA, 13005, France
Anesthesia causes respiratory changes and complications, which are the main causes of complications and anesthesia-related deaths.
Among the complications, the rapid appearance of lung atelectasis is well known, deteriorating the hematosis during anesthesia, and inducing secondary pulmonary complications.
Prevention or limitation of the atelectasis would be a way to improve the safety of patients who have a limited respiratory function.
The application of a positive expiratory pressure (PEP) is an effective prevention method for atelectasis, that has been demonstrated only in patients under mechanical ventilation.
The high flow nasal cannula is a non-invasive technique easy to perform and allowing a PEP. High flow nasal cannula is safe to use, and the interface is free from local skin complications.
Chest X-ray (bad sensibility) or CT are usually used for the diagnosis of atelectasis, but these two exams involve irradiation for patient. MRI and pulmonary ultrasonography has now been validated in adults. The investigators has a long experience of anesthesia in spontaneous ventilation in children for MRI. MRI are relatively long, and allow to investigate the atelectasis with only a short additional acquisition time.
Thus, it would be the first study on the effect of the PEP on the impact and the volume of the atelectasis during general anesthesia in spontaneous ventilation in children. By the way this is the first study on lung's anatomical effects of high flow nasal cannula.
It is a monocentric, intervention, randomized, superiority study whose main purpose is to show the reduction of the atelectasis through the use of high flow nasal cannula versus a high concentration mask for pediatric anesthesia during MRI.
The studied population is all the children between 6 months and 5 years with a pediatric indication of general anesthesia for MRI.
The primary goal is to show a reduction of volume (cm3) of the atelectasis via the application of a PEP by high flow nasal cannula.
The main assessment criteria is the ratio of atelectasis volume/total lung volume.
The prevalence of the atelectasis will be evaluated by MRI lung and measured using 3D reconstruction software. The duration of the examination and the anesthesia is slighty lengthened, 3 to 5 minutes for a 40 minutes' exam.
The secondary objective is to show a match between the atelectasis on MRI and ultrasound.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
high flow nasal canula to obtain a positive expiratory pressure
Time frame: 40 minutes
volume (cm3) of the total lung.
The main assessment criteria is the ratio of atelectasis volume/total lung volume.
The prevalence of the atelectasis will be evaluated by MRI lung and measured using 3D reconstruction software.
Time frame: 40 minutes
volume (cm3) of the atelectasis via the application of a PEP by high flow nasal cannula.
The main assessment criteria is the ratio of atelectasis volume/total lung volume.
The prevalence of the atelectasis will be evaluated by MRI lung and measured using 3D reconstruction software.
Time frame: 15 to 45 minutes after begining general anesthesia
Lung ultrasonography will be pratice in recovery room, just after the MRI. The Lung ultrasonography score will be collected.
Assistance Publique Hopitaux De Marseille
Other
Prevention of Atelectasis, Via High Flow Nasal Cannula to Obtain a PEP, During General Anesthesia for MRI by Sevoflurane in Children, Evaluated by Lung MRI and Echography
Acronym: PREVAT-PED
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05963945
Atelectasis, Cardiomegaly
Havířov, Czechia
View Trial DetailsNCT07041567
Atelectasis, Bariatric Surgery
Istanbul, Goztepe, Turkey (Türkiye)
View Trial DetailsNCT04663958
Abdominal Surgery, Atelectasis
Ankara, Yenimahalle, Turkey (Türkiye)
View Trial DetailsNCT03098524
Atelectasis, Bleeding
Neuilly-sur-Seine, Île-de-France Region, France
View Trial Details